This event has run. Thank you to our speakers, sponsors, and delegates who joined us for the 2026 summit.

Radiopharm Doses First Patient in Phase I Prostate Cancer Radiotherapy Study
Alpha‑Emitting PSMA Therapies Gain Momentum Across Radiopharma Leaders
Ratio Therapeutics Highlights the Next Wave of Radiopharmaceutical Manufacturing Standards
Radiopharma Veterans From Novartis‑Built Platforms Strengthen Emerging Biotechs
Radiopharma Takes Center Stage as Global Biopharma Partnering Accelerates

Building a Preclinical Package That Enables Clinical Success: Key Considerations Before First-in-Human Studies

Building a Preclinical Package That Enables Clinical Success: Key Considerations Before First-in-Human Studies

11:30 am - Wednesday 22nd July 2026

Understanding the critical components of a robust preclinical package required to support successful clinical entry for radiopharmaceutical programmes
Exploring how nonclinical study design, translational evidence and regulatory expectations influence development timelines and downstream success
Identifying the most common gaps and challenges encountered during preclinical development and how to proactively address them

Speakers:

Alyssa Vito

Chief Development Officer

Stealth Mode Biotech